Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping review.
autoimmune diseases
qualitative research
vaccination
Journal
RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
06
07
2022
accepted:
01
09
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
28
12
2022
Statut:
ppublish
Résumé
Patients with autoimmune inflammatory rheumatic diseases (AIRD) often have lower vaccination coverage rates compared with the general population, despite being disproportionately affected by infectious complications. We aim to systematically review the literature regarding vaccination willingness and hesitancy in AIRD. A scoping review was conducted in PubMed, EMBASE and the Cochrane Library in June 2021. Study selection was performed by two independent reviewers and data were extracted using a standardised form. Risk of bias was assessed using instruments from McMaster University. Identified barriers were categorised into the WHO's measuring behavioural and social drivers (BeSD) of vaccination conceptual model. The search yielded 1644 hits of which 30 publications were included (cross-sectional studies based on interviews (n=27) and intervention studies (n=3)). The majority of studies reported barriers to influenza and pneumococcal vaccination only (n=9) or in combination with another vaccination (n=8) from the patients' perspective. Only one study assessed the view of rheumatologists. Coverage of domains matched to the BeSD model suggests a lack of awareness of infection risk by both patients and physicians. Patients mainly mentioned behavioural and social factors that negatively influenced their willingness to be vaccinated while physicians mentioned organisational deficits as major barriers. The view on vaccination in patients with AIRD diverges between patients and rheumatologists. Our results show that in-depth counselling on vaccines is important for patients, whereas physicians need support in implementing specific immunisation recommendations. The themes identified provide a starting point for future interventions to improve vaccine rates in patients with AIRD.
Identifiants
pubmed: 36562767
pii: rmdopen-2022-002562
doi: 10.1136/rmdopen-2022-002562
pmc: PMC9748992
pii:
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Ann Rheum Dis. 2020 Jan;79(1):39-52
pubmed: 31413005
Vaccine. 2021 Mar 12;39(11):1593-1597
pubmed: 33610375
J Rheumatol. 2020 May 1;47(5):770-778
pubmed: 31308211
Rheumatology (Oxford). 2021 Oct 9;60(SI):SI68-SI76
pubmed: 33983432
Clin Rheumatol. 2020 Mar;39(3):747-754
pubmed: 31820135
J Rheumatol. 2017 Dec;44(12):1794-1803
pubmed: 28966211
RMD Open. 2019 Sep 9;5(2):e001035
pubmed: 31565247
J Clin Rheumatol. 2012 Aug;18(5):237-41
pubmed: 22832287
Ann Rheum Dis. 2007 Jun;66(6):837-8
pubmed: 17513572
Hum Vaccin Immunother. 2019;15(5):1100-1105
pubmed: 30689509
BMC Musculoskelet Disord. 2016 Aug 04;17:322
pubmed: 27491386
Vaccine. 2018 Aug 6;36(32 Pt B):4875-4879
pubmed: 29980390
Rheumatol Int. 2017 Feb;37(2):229-237
pubmed: 27878345
ACR Open Rheumatol. 2022 Jan;4(1):3-7
pubmed: 34613668
RMD Open. 2021 Apr;7(1):
pubmed: 33832974
Lupus. 2019 May;28(6):794-796
pubmed: 31042124
Ann Rheum Dis. 2003 Jul;62(7):685
pubmed: 12810440
Rheumatology (Oxford). 2010 Mar;49(3):600-6
pubmed: 20040532
Joint Bone Spine. 2016 Mar;83(2):155-9
pubmed: 26725745
Vaccines (Basel). 2019 Dec 21;8(1):
pubmed: 31877764
Semin Arthritis Rheum. 2015 Jun;44(6):666-71
pubmed: 25701500
Am J Manag Care. 2016 Mar;22(3):161-7
pubmed: 27023021
Rheumatol Int. 2021 May;41(5):895-902
pubmed: 33661331
BMC Musculoskelet Disord. 2007 Jul 04;8:58
pubmed: 17610723
Arthritis Rheum. 2002 Sep;46(9):2287-93
pubmed: 12355475
Rheumatology (Oxford). 2018 Aug 01;57(8):1439-1447
pubmed: 29757414
Sci Rep. 2022 Apr 26;12(1):5966
pubmed: 35474313
Vaccine. 2015 Mar 17;33(12):1446-52
pubmed: 25659279
Ann Rheum Dis. 2018 Jun;77(6):905-910
pubmed: 29592917
Rheumatology (Oxford). 2007 Apr;46(4):715-6
pubmed: 17244667
Ann Rheum Dis. 2021 Oct;80(10):e168
pubmed: 33962960
Rheumatol Int. 2021 Jun;41(6):1105-1114
pubmed: 33779780
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Int J Rheum Dis. 2020 Nov;23(11):1526-1533
pubmed: 32965794
Clin Rheumatol. 2021 Feb;40(2):575-579
pubmed: 33030631
Joint Bone Spine. 2011 Jul;78(4):374-7
pubmed: 21169045
Rheumatology (Oxford). 2004 Aug;43(8):1055
pubmed: 15258293
Joint Bone Spine. 2016 Mar;83(2):237-8
pubmed: 26190453
Clin Rheumatol. 2021 Feb;40(2):477-489
pubmed: 32621081
Hum Vaccin Immunother. 2021 May 4;17(5):1420-1425
pubmed: 32991221
Ann Rheum Dis. 2016 Jun;75(6):965-73
pubmed: 26984008